Science
Mechanism of Action
The proposed mechanism involving TRPV1 antagonism, which contributes to soothing and anti-stinging sensations, is primarily associated with the trans isomer of 4-tert-butylcyclohexanol. In contrast, CIS-2-TERT-BUTYLCYCLOHEXANOL has been reported as inactive in mitigating stinging or burning sensations on the skin.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
This ingredient's primary role is as a fragrance, not an active compound intended for specific skin benefits, thus it does not fall under typical 'dusting' concerns related to efficacy at minimal concentrations.
The Formula
Formulation
Stability
The cis isomer demonstrates reduced stability when compared to its trans counterpart. This is primarily due to steric strain resulting from the bulky tert-butyl groups positioned on the same side of the cyclohexane ring. Its distinctively strong and unpleasant earthy odor makes it less suitable for topical cosmetic formulations at concentrations exceeding 0.3 wt. %.
Safety
Safety Profile
CIS-2-TERT-BUTYLCYCLOHEXANOL generally does not meet GHS hazard criteria in 95.2% of available reports. However, a comprehensive RIFM safety assessment for 4-tert-butylcyclohexanol (encompassing both cis and trans isomers) identified it as a skin sensitizer, with a No Expected Sensitization Induction Level (NESIL) of 17000 μg/cm2 based on read-across data. While a specific maximum concentration for the cis isomer's safety is not established, its unpleasant odor limits its practical use in cosmetic formulations to below 0.3 wt. %.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Considering its lack of active skincare benefits, inherent instability, unpleasant odor at functional concentrations, and identified skin sensitization potential, CIS-2-TERT-BUTYLCYCLOHEXANOL is not suitable for precision skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources